LON:OXP

Oxford Pharmascience Group (OXP) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
16,260 shs
Average Volume
803,502 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OXP stock logo

About Oxford Pharmascience Group Stock (LON:OXP)

Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited.

OXP Stock News Headlines

See More Headlines
Receive OXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Pharmascience Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Electronic Computer Manufacturing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Marcelo Leonardo Bravo
    Chief Executive Officer, Executive Director
  • Christopher Hill
    Chief Financial Officer, Executive Director, Company Secretary
  • David Robert Norwood (Age 48)
    Non-Executive Chairman of the Board
  • James Nicholas Gerald White
    Non-Executive Deputy Chairman of the Board
  • John Geoffery Goddard
    Independent Non-Executive Director
  • Karl Robertson Van Horn (Age 80)
    Independent Non-Executive Director

OXP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Oxford Pharmascience Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford Pharmascience Group investors own include Oxford Biomedica (OXB), International Biotechnology (IBT), Aphria (APHA), Man Group (EMG), Richland Resources Ltd (RLD.L) (RLD), The Restaurant Group (RTN), 32Red (TTR), Haydale Graphene Industries (HAYD) and 326553 (GWP.L) (GWP).

How do I buy shares of Oxford Pharmascience Group?

Shares of OXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:OXP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners